NERV
NERV
NASDAQ · Biotechnology

Minerva Neurosciences Inc

$2.38
-0.18 (-7.03%)
Analyst Consensus
Strong Buy
9
Analysts
Moderate
Coverage
Buy 7 78%
Hold 2 22%
Sell 0 0%
Price Target
Analyst Price Target +69.3% upside
Low Target $3.03
Average Target $4.03
High Target $5.66
Current Price $2.38
Current
$2.38
Target
$4.03
$3.03 $4.03 avg $5.66
Scenario Analysis
Bear Case
$3.03
27.3%
Low target
Base Case
$4.03
+69.3%
Avg target
Bull Case
$5.66
+137.8%
High target
Risk/Reward
5.0x
Highly favorable
Price in Context
52-Week High
$8.80
-73.0% from high
52-Week Low
$1.96
+21.4% from low
Target vs 52W High
$4.03
-54.2% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 38 82% $257.58 -12.5%
AMGN
Amgen Inc
Hold 42 43% $190.87 -59.0%
GILD
Gilead Sciences Inc
Strong Buy 36 83% $362.68 +115.4%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 82% $438.34 -18.5%
MRNA
Moderna Inc
Hold 31 32% $149.45 -35.4%
REGN
Regeneron Pharmaceuticals
Buy 36 72% $76.80 -91.9%
NTRA
Natera Inc
Strong Buy 31 90% $142.91 -55.7%
RVMD
Revolution Medicines Inc
Strong Buy 31 94% $114.11 -35.3%